IlluMine Research Company Profile

Background

Overview

IlluMine Research is a healthcare-focused analytics and artificial intelligence (AI) company dedicated to enhancing healthcare delivery through evidence-based solutions. Founded in 2015, the company specializes in developing transparent, explainable applications that bridge the gap between data science and clinical practice. By integrating advanced data science, machine learning, and AI, IlluMine Research aims to optimize patient outcomes and operational efficiency within healthcare organizations.

Mission and Vision

The company's mission is to transform healthcare delivery by providing evidence-based analytics and AI solutions that complement human expertise. IlluMine Research envisions a healthcare system where data-driven insights lead to improved patient care and operational effectiveness.

Primary Area of Focus

IlluMine Research concentrates on developing custom applications that employ statistical and machine learning methods to inform decision-making processes in healthcare settings. Their solutions address various challenges, including the evaluation of key performance indicators (KPIs), identification of contributing factors to health outcomes, simulation of "what if" scenarios, and predictive analytics for future healthcare trends.

Industry Significance

In an era where healthcare organizations are inundated with data, IlluMine Research's focus on evidence-based analytics and AI is crucial. Their solutions empower healthcare providers to make informed decisions, leading to enhanced patient care and streamlined operations. By emphasizing transparency and explainability, the company fosters trust and facilitates the adoption of advanced analytics in clinical environments.

Key Strategic Focus

Core Objectives

IlluMine Research aims to:

Develop applications that assist healthcare providers in understanding and addressing complex clinical and operational challenges.

Enhance decision-making processes through predictive analytics and AI-driven insights.

Promote the integration of evidence-based practices in healthcare settings.

Specific Areas of Specialization

The company specializes in:

Advanced data science and analytics tailored for healthcare applications.

Machine learning and AI solutions designed to automate processes and optimize decision-making.

Data fusion techniques that integrate disparate data sources for a unified organizational view.

Key Technologies Utilized

IlluMine Research employs:

Statistical modeling and machine learning algorithms for predictive analytics.

AI-driven tools for automating manual processes and enhancing clinical decision support.

Data integration platforms that consolidate information from multiple electronic health record (EHR) systems.

Primary Markets Targeted

The company's solutions are primarily targeted at:

Healthcare providers seeking to improve patient outcomes and operational efficiency.

Clinical researchers aiming to enhance the design and execution of clinical trials.

Healthcare organizations looking to integrate advanced analytics into their decision-making processes.

Financials and Funding

Funding History

As of March 2026, specific details regarding IlluMine Research's total funds raised, recent funding rounds, and notable investors are not publicly disclosed. The company operates as a privately held entity, and such financial information is not readily available in public records.

Intended Utilization of Capital

While specific details on the utilization of capital are not publicly disclosed, it is reasonable to infer that funding has been directed towards:

Research and development of new analytics and AI solutions.

Expansion of the company's product offerings.

Enhancement of data integration capabilities.

Scaling operations to serve a broader client base.

Pipeline Development

Key Pipeline Candidates

IlluMine Research is developing several applications, including:

Tools for evaluating and refining KPIs to ensure they accurately reflect healthcare objectives.

Applications that identify and analyze contributing factors to health outcomes, facilitating targeted interventions.

Simulation models that allow healthcare providers to explore various scenarios and their potential impacts.

Predictive models that forecast future healthcare trends and inform strategic planning.

Stages of Development

The company is in the advanced stages of developing these applications, with several solutions already deployed in healthcare settings. Ongoing efforts focus on refining these tools and expanding their capabilities to address a wider range of healthcare challenges.

Target Conditions

The applications are designed to address various conditions, including:

Operational inefficiencies within healthcare organizations.

Clinical decision-making processes.

Patient outcome optimization.

Clinical trial design and execution.

Anticipated Milestones

IlluMine Research anticipates:

Further deployment of their applications across diverse healthcare settings.

Continuous enhancement of AI capabilities to improve predictive accuracy.

Expansion of data integration features to support a broader range of EHR systems.

Technological Platform and Innovation

Proprietary Technologies

IlluMine Research has developed proprietary technologies, including:

Advanced predictive analytics platforms tailored for healthcare applications.

AI-driven tools that automate manual processes and support clinical decision-making.

Data fusion technologies that integrate disparate data sources for a unified organizational view.

Significant Scientific Methods

The company employs:

Statistical modeling techniques for analyzing complex healthcare data.

Machine learning algorithms that adapt and improve over time to enhance predictive capabilities.

Causal inference methods to identify and understand relationships within healthcare data.

AI-Driven Capabilities

IlluMine Research's AI capabilities include:

Automated data processing and analysis to reduce manual workload.

Predictive modeling that forecasts healthcare trends and outcomes.

Decision support systems that provide actionable insights to healthcare providers.

Leadership Team

Key Executives

Phillip Middleton, PhD – Founder and CEO

Phillip Middleton returned to mathematical statistics and machine learning/AI after 25 years as a physician assistant in neurosurgery. His broad experiences sparked his interest in developing digital tools that can truly impact healthcare.

Firyali Omondi Reid – Director, Clinical Compliance and Outreach

Firyali brings over 20 years of clinical experience in nursing and healthcare administration to the team, ensuring that solutions align with real-world healthcare needs.

Seth Karlin – Director, Sales and Marketing

Seth has decades of experience across multiple industries, providing valuable insights into client needs and guiding the company's sales and marketing strategies.

Emily Rodriguez – Data Science Lead, Epidemiology

Emily leads data science initiatives, focusing on developing robust predictive models that assist healthcare providers in making data-driven decisions.

Prasanth Cherukuri – Data Engineering Chief Architect

Prasanth oversees data engineering and development efforts, ensuring that solutions are scalable, secure, and user-friendly.

Jarret Wilson – Software Engineering Lead

Jarret brings extensive experience in clinical informatics and healthcare IT, contributing to the development of the company's software solutions.

Competitor Profile

Market Insights and Dynamics

The healthcare analytics and AI market is experiencing significant growth, driven by the increasing need for data-driven decision-making and operational efficiency in healthcare organizations. Advancements in AI and machine learning are enabling more sophisticated analyses, leading to improved patient outcomes and streamlined operations.

Competitor Analysis

IlluMine Research operates in a competitive landscape with several key players offering similar solutions. Notable competitors include: